[go: up one dir, main page]

MXPA05009096A - Metodo de cultivo celular libre de animal. - Google Patents

Metodo de cultivo celular libre de animal.

Info

Publication number
MXPA05009096A
MXPA05009096A MXPA05009096A MXPA05009096A MXPA05009096A MX PA05009096 A MXPA05009096 A MX PA05009096A MX PA05009096 A MXPA05009096 A MX PA05009096A MX PA05009096 A MXPA05009096 A MX PA05009096A MX PA05009096 A MXPA05009096 A MX PA05009096A
Authority
MX
Mexico
Prior art keywords
animal
cell culture
exogenous
relates
animal origin
Prior art date
Application number
MXPA05009096A
Other languages
English (en)
Inventor
Maggetto Carine
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of MXPA05009096A publication Critical patent/MXPA05009096A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencion se refiere a un proceso para cultivo celular diploide de animal, preferentemente de humano, dependiente de sujecion, en la ausencia de componentes exogenos de origen animal primario, y a un medio de cultivo celular substancialmente libre de componentes exogenos de origen animal primario adecuados para llevar a cabo dicho proceso. En particular, la invencion se refiere a un medio de cultivo celular que comprende al menos uno, mas preferentemente varios factores de crecimiento libres de animal exogenos. La presente invencion tambien se refiere a un proceso para cultivar celulas diploide de animal, preferentemente de humano dependientes de sujecion en un medio de acuerdo a la invencion, incluyendo el uso de un substituto de tripsina de origen no animal para pasar celulas. La invencion se refiere ademas un proceso para producir virus, vacunas virales y lo similar.
MXPA05009096A 2003-03-03 2004-03-01 Metodo de cultivo celular libre de animal. MXPA05009096A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0304799.0A GB0304799D0 (en) 2003-03-03 2003-03-03 Novel method
PCT/EP2004/002067 WO2004078955A1 (en) 2003-03-03 2004-03-01 Animal-free cell culture method

Publications (1)

Publication Number Publication Date
MXPA05009096A true MXPA05009096A (es) 2005-10-19

Family

ID=9953995

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05009096A MXPA05009096A (es) 2003-03-03 2004-03-01 Metodo de cultivo celular libre de animal.

Country Status (17)

Country Link
US (1) US8034617B2 (es)
EP (3) EP2186885A1 (es)
JP (2) JP4787739B2 (es)
KR (1) KR101242090B1 (es)
CN (2) CN1756837B (es)
AU (1) AU2004217807B2 (es)
BR (1) BRPI0407636A (es)
CA (1) CA2517327A1 (es)
CO (1) CO5601047A2 (es)
GB (1) GB0304799D0 (es)
IS (1) IS7992A (es)
MA (1) MA27631A1 (es)
MX (1) MXPA05009096A (es)
NO (1) NO20054124L (es)
NZ (1) NZ541908A (es)
RU (1) RU2369634C2 (es)
WO (1) WO2004078955A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058207A1 (en) 2003-12-11 2005-06-30 Isto Technologies, Inc. Particulate cartilage system
WO2005103235A1 (ja) 2004-04-19 2005-11-03 Denka Seiken Co., Ltd. ウイルスの生産方法
CA2585547A1 (en) * 2004-10-29 2006-05-11 Centocor, Inc. Chemically defined media compositions
CA2601006C (en) 2005-03-10 2012-10-23 Kyoritsu Seiyaku Corporation Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
CA2610315A1 (en) * 2005-06-03 2006-12-07 Biovitrum Ab (Publ) Process for cultivating animal cells comprising the feeding of plant-derived peptones
WO2007025290A2 (en) 2005-08-26 2007-03-01 Isto Technologies, Inc. Implants and methods for repair, replacement and treatment of joint disease
EP1764117A1 (en) 2005-09-20 2007-03-21 Zimmer GmbH Implant for the repair of a cartilage defect and method for manufacturing the implant
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US20090012629A1 (en) 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
FI20075417A0 (fi) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
CN102317440B (zh) 2008-01-09 2014-12-03 塞尔卡有限公司 改进的培养基添加剂及其应用方法
CA2752809A1 (en) 2009-02-17 2010-08-26 Glaxosmithkline Biologicals Sa Inactivated dengue virus vaccine with aluminium-free adjuvant
BR112012027282B1 (pt) * 2010-04-26 2020-09-29 Novartis Ag Meio de cultura de células aperfeiçoado e processo para a produção de um polipeptídeo recombinante
CN101831415B (zh) * 2010-05-12 2012-05-30 江苏博立生物制品有限公司 一种提高糖化酶发酵水平的方法
KR102117921B1 (ko) * 2011-02-28 2020-06-03 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 세포 배양 시스템
HUE030541T2 (en) 2011-12-08 2017-05-29 Yeda Res & Dev Mammalian fetal lung cells and their therapeutic use
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
US20130281355A1 (en) * 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
JP6041199B2 (ja) * 2012-09-14 2016-12-07 国立大学法人大阪大学 三次元細胞培養体の製造方法
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
EP3310388B1 (en) 2015-06-18 2021-10-06 Yeda Research and Development Co., Ltd. Conditioning protocols and use of same for tissue regeneration
US10004795B2 (en) * 2015-09-08 2018-06-26 Fundacao Butantan Process for preparing an attenuated tetravalent dengue vaccine
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
CN105567628B (zh) * 2016-01-30 2019-07-12 令世鑫 一种全悬浮培养mdck细胞的低血清培养基
CN105695393B (zh) * 2016-03-24 2019-09-10 友康恒业生物科技（北京）有限公司 一种mdck细胞无血清培养基及其用途和制备
CN105779376B (zh) * 2016-03-24 2019-08-30 友康恒业生物科技（北京）有限公司 一种流感病毒分离无血清培养基及其用途和制备
KR101925079B1 (ko) * 2017-05-24 2018-12-04 가천대학교 산학협력단 Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법
CN107432931B (zh) * 2017-08-03 2018-04-13 长春祈健生物制品有限公司 一种微载体培养水痘病毒制备疫苗的方法
CN113227354A (zh) * 2019-01-17 2021-08-06 勃林格殷格翰动物保健美国公司 用于禽类疫苗生产的无血清培养基及其用途
PE20230409A1 (es) 2019-12-31 2023-03-07 Air Protein Inc Composiciones alimenticias con alto contenido en proteinas
IL294703A (en) * 2020-01-24 2022-09-01 Air Protein Inc Microorganism-derived protein hydrolysates, and methods of preparation and use thereof
CN113373107B (zh) * 2021-01-29 2022-12-30 上海生物制品研究所有限责任公司 一种大规模制备传代鸡胚细胞生产病毒的方法
WO2024039216A1 (ko) * 2022-08-19 2024-02-22 셀미트주식회사 동물세포 또는 동물 세포주의 배양방법
CN115627255B (zh) * 2022-12-01 2023-04-07 天信和(苏州)生物科技有限公司 一种采用低血清培养基培养人二倍体细胞的方法
CN119979445B (zh) * 2025-04-10 2025-09-09 四川大学 一种培养基、口腔黏膜上皮细胞模型，及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94611A (en) * 1989-06-05 1994-12-29 Organogenesis Inc Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4115722A1 (de) 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
RU2057176C1 (ru) * 1992-05-20 1996-03-27 Институт генетики АН Республики Молдова Питательная среда для культивирования клеток человека и животных
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
PT666751E (pt) 1992-09-18 2002-01-30 Smithkline Beecham Biolog Mutantes da estirpe hm-175 do virus da hepatite a para utilizacao como vacinas da hepatite a
CN1088984A (zh) * 1993-11-11 1994-07-06 江西省医学科学研究所 一种用于造血祖细胞培养的无血清培养基
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
CA2415990C (en) 1994-11-10 2009-07-07 Immuno Aktiengesellschaft Method for producing biologicals in protein-free culture
WO1998000521A1 (fr) * 1996-06-28 1998-01-08 The Green Cross Corporation Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives
WO1998004680A1 (en) * 1996-07-26 1998-02-05 University Of Manitoba Serum-free medium for growth of anchorage-dependant mammalian cells
ATE399855T1 (de) * 1996-10-10 2008-07-15 Invitrogen Corp Tierzellkulturmedium mit pflanzlichen nährstoffen
AU7984498A (en) * 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2775983B1 (fr) 1998-03-13 2000-11-10 Pasteur Merieux Serums Vacc Milieu et procede de propagation et de multiplication virales
WO1999057246A1 (en) * 1998-05-01 1999-11-11 Life Technologies, Inc. Animal cell culture media comprising non-animal or plant-derived nutrients
US6406909B1 (en) * 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
US6623959B2 (en) * 2001-06-13 2003-09-23 Ethicon, Inc. Devices and methods for cell harvesting

Also Published As

Publication number Publication date
JP4787739B2 (ja) 2011-10-05
US20060183224A1 (en) 2006-08-17
JP2006519023A (ja) 2006-08-24
IS7992A (is) 2005-08-18
BRPI0407636A (pt) 2006-02-21
NO20054124L (no) 2005-09-27
AU2004217807A1 (en) 2004-09-16
RU2369634C2 (ru) 2009-10-10
NO20054124D0 (no) 2005-09-05
EP2186885A1 (en) 2010-05-19
RU2005125606A (ru) 2006-03-10
NZ541908A (en) 2008-04-30
JP2010273683A (ja) 2010-12-09
CN1756837A (zh) 2006-04-05
CN101200705A (zh) 2008-06-18
AU2004217807B2 (en) 2009-06-25
CA2517327A1 (en) 2004-09-16
WO2004078955A1 (en) 2004-09-16
CN1756837B (zh) 2010-05-26
EP1599580A1 (en) 2005-11-30
KR20050105509A (ko) 2005-11-04
EP2192175A1 (en) 2010-06-02
US8034617B2 (en) 2011-10-11
KR101242090B1 (ko) 2013-03-08
GB0304799D0 (en) 2003-04-09
MA27631A1 (fr) 2005-11-01
CO5601047A2 (es) 2006-01-31

Similar Documents

Publication Publication Date Title
MXPA05009096A (es) Metodo de cultivo celular libre de animal.
MX2007005132A (es) Medios libres de proteina animal para cultivo de celulas.
DE69740002D1 (de) Tierzellen und verfahren für die replikation von influenza viren
DK1201749T3 (da) Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter
WO1999057246A8 (en) Animal cell culture media comprising non-animal or plant-derived nutrients
PL374782A1 (en) Animal protein free media for cultivation of cells
WO2003014313A3 (en) Alternative compositions and methods for the culture of stem cells
SG149003A1 (en) Gene expression technique
MX2009002741A (es) Lineas de celulas mdck que soportan el crecimiento viral para altos titulos y proceso de biorreactor que utiliza las mismas.
WO2006045110A3 (en) High cell density process for growth of listeria
EA200200604A1 (ru) Производство вакцин
IL160445A0 (en) A unit and a process for carrying out high cell density fermentation
NZ597742A (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
DE60334025D1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
TW200636068A (en) A method of culturing a cell and use of the same
CY1111253T1 (el) Μεθοδος για την παραγωγη ιικου υλικου
AU2002212555A1 (en) Yeast derived vaccine against ipnv
UA100849C2 (ru) Способ репликации вируса гриппа в культуре
ATE414141T1 (de) Verfahren zur kultivierung humaner chondrozyten
WO2004015091A3 (en) Preparation of type ii pneumocytes from stem cells
WO2004078916A3 (en) In vitro micro-organs, and uses related thereto
TW200732475A (en) Pulmonary stem cells, related methods and kits
EP1517987A4 (en) PULMONARY CELLS OF THE RAT DES COTONNIERS FOR VIRUS CULTURE
EP1762609A3 (en) Serum-free medium for producing substances of interest
DE602004029789D1 (de) Keratinozyten-kulturverfahren und verwendung davon

Legal Events

Date Code Title Description
FG Grant or registration